Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

In this study, those who had the Zostavax vaccine had a 3.5% point reduction in a new dementia diagnosis over seven years, ...

The latest numbers from the Centers for Disease Control and Prevention show the measles outbreak has surpassed 1,000 cases ...

Researchers found people given a shingles vaccine had a 23% lower risk of cardiovascular events, including stroke, heart ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...